Our members have asked us what is precision medicine and what does it mean?

Our Chief Scientific Officer, Andy Hall, was happy to share this short summary.

bit.ly/3J7kp2k

#precisionmedicine
#cancerresearch
#clinicaltrials
#healthtechnology

Genetic sequencing - buzz words of the moment when it comes to cancer and how to treat it.

Our members have asked us what genetic sequencing is & why it is so important. Our CSO, Andy Hall, shares his thoughts with you all ⬇️

bit.ly/3U5FHng

We are delighted to share Maggy's blog with you this week.

Following a brief screening call with the member engagement team, Maggy tells us she felt:
✔️ Relief
✔️ Listened to
✔️ Hopeful

Follow this link to read more ➡️ bit.ly/3xiQmlB

#Cancerresearch
#Clinicaltrials

Many members of the RareCan community will have celebrated Ramadan over the last month.

We wish them all Eid Mubarak.

Our Chief Scientific Officer, Andy Hall, is happy to answer questions from members within our community.

This week his focus is on Phase 1 trials and why join them?

bit.ly/3VNa4QE

We should not underestimate the impact you can make when you improve treatments & then consider this treatment or elements of it in other forms of cancer.

The results offer hope to many.

bit.ly/3PEMgKV

Glioblasma is a very difficult tumour to treat so any progress in stopping its growth represents real progress.

Although there is obviously a long way to go this new approach offers hope that longer-lasting responses may be on the horizon

go.nature.com/4cuNsds

Research plays a large part in in finding better treatments and improving early detection of cancer.

The increased number of available treatments has also contributed as new precision medicines being developed

bit.ly/4chFdRI

#precisionmedicine
#clinicaltrials
#cancer

It is so uplifting to hear such a positive outcome following a glioblastoma diagnosis.

Unfortunately this trial had to close due to lack of recruitment.

However, research like this is vital for other patients with glioblastoma in the future!

bit.ly/3TgWwtv

This Spring, we have reached some exciting key milestones in our growth and development.

🚀 We have launched new services to our members.

✔️ Agreed terms of a new commercial contract.

🎉 Won an Innovate UK grant.

F out more: ➡️ bit.ly/49UQOoA

We are proud to celebrate that 64% of the team at RareCan are women!

They include our founders, our main board and support teams as well as a number of our partnerships in the rare cancer space.

Happy International Women's Day!

#inspireinclusion
#IWD2024
#togetherwecan

It is wonderful to see success in clinical trials around the world that impacts on patients with a rare form of cancer so positively.

bit.ly/3SUMn5R

#ClinicalTrials
#Research

Knowing there is an experienced person at the end of the phone who will listen and help you navigate the world of clinical trials makes a big difference to anyone with cancer.

Debbie and Lindsay are here to help.

Book a call here➡️ bit.ly/3UBZb3q

This is an exciting development for all cancer patients, but especially for those with rare cancer.

go.nature.com/3uwNAYD

Advances in cancer research happen when clinicians find the right patients to help with their research.

This is an exciting step forward for the future precision medicine within early stage clinical trials.

bit.ly/3SNXy1c

#cancerresearch
#clinicaltrials

This is a wonderful example of exploring new ways to diagnose rare cancers early and shows us that it doesn't have to mean expensive and complex technologies are a given.

Can a capsule sponge change how we diagnose oesophageal cancer? bit.ly/48KeThb

#cancerresearch

#WorldCancerDay gives us all the opportunity to stand together with our friends and family, our members and our partners to help accelerate rare cancer research and improve treatments and outcomes in cancer care that will impact everyone 🌎.

The newest member to welcome to our team this month is Adam Ogwu.

Adam joins us with a breadth of knowledge from the pharmaceutical industry and supply chain projects and we are delighted to have him on board.

#talent
#teambuilding
#cancerresearch
#togetherwecan

This week we welcome Andreea Prisecaru, Business Development Executive who brings with her a background of clinical research experience.

To find out more about how research is connecting its members to clinical trials, follow this link: ➡️ bit.ly/427LGKv

#cancer

We have started 2024 with a number of new members to the team to help us grow.

This week we welcome Yash Tomar, Business Development Executive who brings with him knowledge and experience of working with startups.

Visit bit.ly/48BkjuE to find out more.

#cancer